BioNTech SE BNTX
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 1,108.16% | -11.11% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1,108.16% | -11.11% | |||
| Cost of Revenue | -6.24% | 35.05% | |||
| Gross Profit | 13,677.52% | -81.69% | |||
| SG&A Expenses | -10.69% | 30.39% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -73.38% | 826.64% | |||
| Total Operating Expenses | -7.10% | 19.10% | |||
| Operating Income | 145.36% | -24.34% | |||
| Income Before Tax | 125.58% | -50.26% | |||
| Income Tax Expenses | 197.92% | -4.08% | |||
| Earnings from Continuing Operations | 122.24% | -53.40% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 122.24% | -53.40% | |||
| EBIT | 145.36% | -24.34% | |||
| EBITDA | 222.11% | -4.03% | |||
| EPS Basic | 122.60% | -53.37% | |||
| Normalized Basic EPS | 160.29% | -36.13% | |||
| EPS Diluted | 122.30% | -53.37% | |||
| Normalized Diluted EPS | 159.47% | -36.13% | |||
| Average Basic Shares Outstanding | -1.58% | 0.02% | |||
| Average Diluted Shares Outstanding | -0.23% | 0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||